middle.news
Orthocell Launches Remplir™ Nerve Repair in US with First Successful Surgery
9:12am on Friday 27th of June, 2025 AEST
•
Healthcare
Read Story
Orthocell Launches Remplir™ Nerve Repair in US with First Successful Surgery
9:12am on Friday 27th of June, 2025 AEST
Key Points
First US surgery using Remplir™ completed in Ohio
Remplir™ FDA-cleared in April 2025 for nerve repair
14 specialist distributors appointed across 25 US states
US market valued at approximately US$1.6 billion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE